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A REINFORCEMENT LEARNING APPROACH
TO OBTAIN INTERVENTION STRATEGIES IN MEDICINE
Radhika Poolla
ABSTRACT

Medical decision problems are extremely complex owing to their dynamic nature,
large number of variable factors, and the associated uncertainty. Decision support
technology entered the medical field long after other areas such as the airline industry and
the manufacturing industry. Yet, it is rapidly becoming an indispensable tool in medical
decision making problems including the class of sequential decision problems. In these
problems, physicians decide on a treatment plan that optimizes a benefit measure such as
the treatment cost, and the quality of life of the patient. The last decade saw the
emergence of many decision support applications in medicine. However, the existing
models have limited applications to decision problems with very few states and actions.
An urgent need is being felt by the medical research community to expand the
applications to more complex dynamic problems with large state and action spaces. This
thesis proposes a methodology which models the class of sequential medical decision
problems as a Markov decision process, and solves the model using a simulation based
reinforcement learning (RL) algorithm. Such a methodology is capable of obtaining near
vi

optimal treatment strategies for problems with large state and action spaces. This
methodology overcomes, to a large extent, the computational complexity of the valueiteration and policy-iteration algorithms of dynamic programming. An average reward
reinforcement-learning algorithm is developed. The algorithm is applied on a sample
problem of treating hereditary spherocytosis. The application demonstrates the ability of
the proposed methodology to obtain effective treatment strategies for sequential medical
decision problems.
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CHAPTER 1
INTRODUCTION

Ability to reason differentiates humans from other species. Reasoning leads
humans to perceive, understand, analyze, and act. Humans act by making decisions and
this process happens almost every minute of our lives. In situations involving many
variables and possible decisions, decision support systems provide useful tools. A
decision support system translates the real life scenario into a mathematical model for
analysis. A set of decisions usually evolves from this process and, generally, the decision
that best satisfies the objective of the analysis is carried out.
Decision support systems have been gaining usage in many application areas
including, pharmacy, manufacturing, finance, armed forces, aviation industry, and health
sciences. Because of the complexity of decision making, health sciences have been a new
and fast growing field of application. Factors such as multiple variables, uncertainty of
action outcomes, difficulty of incorporating input obtained from domain experts into the
model building process, and the time varying nature of the problems pose a tough
challenge to the decision support experts as they try to fit such complexities into
mathematical frameworks, which are more parameterized. Techniques from the fields of
Statistics and Probability are proving useful to model some of these complex situations
efficiently and to arrive at the best possible decisions.

1

1.1 Sequential decision problems
Diagnostic testing, therapy planning, and other clinical scenario, comprise of the
physical condition of the patients, the interventions, which are diagnostic tests and
treatments, or a combination of both. These, medical scenarios, usually, comprise of
problems which, involve a trade-off between certain events affecting the health of a
patient and the risk of a certain intervention to avert the events. Both the associated risk
and the health of a patient may vary over time, which makes the situation uncertain for
the physician to predict accurately. The objective of such medical problems is to find a
suitable therapeutic plan for the patient under observation, which would maximize the
quality of life of the patient in a cost effective manner.
A typical sequential decision problem arises when a patient approaches the
physician, and the physician, depending upon the patient’s health situation, decides to
either intervene immediately or to wait and see for some time, with the objective of
maximizing the quality of life for the patient. If the physician believes that the patient’s
life is at risk or the patient’s health would be severely affected if he or she were left in the
same condition, the physician might opt for an intervention. But if the physician is unsure
about the need for an intervention and prefers to keep the patient under observation, then,
a preferred strategy could be ‘wait and see’. Questions listed below could arise in the case
of adopting a ‘wait and see’ strategy.
How long should the physician observe the patient before the decision is
revisited?
Should the patient’s condition be continuously monitored or in discrete intervals?
2

In the case of interventions, the side effects from the interventions can lead the
patient into a different situation, which the physician may not be able to predict with
certainty. Moreover, there could be many modes of interventions, such as medicinal and
surgical. Selecting a mode that would provide the best possible treatment to the patient at
that particular time and situation could be a difficult task.
Age of the patient and sex might be two other factors, which the physician has to
keep in mind, while taking such a decision. Ethnicity of the patient may not be taken into
consideration. In addition to all these, another problem feature, which confronts the
physician is the dynamicity of the problem. A patient’s physical condition may vary with
time during the course of the treatment. For such problems, decision support systems
could help the physicians in taking quick and efficient decisions to maximize the quality
adjusted life years (QALY) of a patient in the long run. A QALY is a measure of the
quality life that the patient enjoys in a year.
1.2 Some medical decision problems
1.2.1

Spontaneous pnemothorax
The problem of finding an optimal strategy for primary spontaneous

pneumothorax, (Lin et al. (2002) [1]), in young men is a typical decision problem, that
falls under the category of intervention problems. This has been modeled using a Markov
decision process with a state space of five and an action space of six. The objective was
to maximize the quality adjusted life years of a patient.

3

1.2.2

Chronic angina (chest pain)
In the case of chronic stable angina, the decision problem involved is to determine

the treatment and the time of treatment such that the quality adjusted life expectancy of a
patient is optimized. The actions usually available in this scenario are medical treatments,
percutaneous transluminal angioplasty, and coronary artery bypass graft. While the
selected treatment progresses, complications occur requiring other decisions. Hence, the
sequence of decisions taken depending on the situation of a patient is very crucial to
maximize the objective function, the quality-adjusted life expectancy. This problem was
modeled in the literature as a Markov decision process (MDP) having five state variables
and three actions (Leong T.Y. (1994) [2]).
1.2.3 Chronic cough
This problem, (Lin et al. (2002) [3]), involves, finding the most cost-effective
management strategy, out of the available strategies, to treat chronic unexplained cough.
The model used is a MDP with six treatment strategies.
1.2.4

Severe head injury management
In the case of severe head injury, (Harmanec et al. (1999) [4]), the management

becomes extremely difficult owing to the time-critical nature of the injury, the
complexities involved in the scenario, and the uncertainty of the intervention procedures.
The decision model presented in [4] considers nine treatment options and the influence
diagram approach.

4

1.2.5

Colorectal cancer follow up
Patients with colorectal cancer undergo curative surgery. The follow up period

after the surgery is very important as there could be either recurrence of the cancer or
development of tumor or both. If the recurrence or tumor is detected at an early stage
during the follow-up, the chance of successful curative treatment can be improved. For
the detection, the doctor needs to perform a series of diagnostic tests.
The decision problem (Zheng et al. (1998) [5]) here, is to find out the optimal
course of tests depending on the stage of health of the patient during the follow-up, which
would ultimately lead to the most cost-effective treatment sequence. This problem was
modeled with seven actions and five state variables as a semi-markov decision process
(SMDP). This model has been solved using the value-iteration technique by using
DynaMol- dynamic decision modeling language, developed by T.Y. Leong (1998) [32],
which takes inputs as the conditional probabilities and the influence view of the problem.
1.2.6

Chronic leukemia
Patients who are born with errors in their immune system and patients who have

diseases like severe aplastic anaemia, and chronic leukemia are treated by allogenic bone
marrow transplantation. But during this transplantation, the patient’s cells could develop
a negative reaction to the donor’s cells. This complication is called graft versus host
disease (GVHD), which occurs frequently and is deadly.
In the case of leukemia patients, mild GVHD helps in preventing disease relapse.
Therefore, though severe GVHD is dangerous, mild form of GVHD is advantageous to
the transplantation. Leukemia patients are treated with immuno suppressive drugs in
5

order to prevent or control GVHD. The dosage of these drugs should be optimal such that
they clear the complication caused by GVHD and at the same time control the GVHD to
benefit the transplantation.
Thus, the decision problem (Paolo Magni et al. (1997) [6]) is to specify both type
and dosage of the drugs in order to either avoid or to induce GVHD according to the
patient’s specific condition and drug’s toxicity. This problem has been modeled as a
MDP with four actions and five state variables forming the state space. Influence views
were used to model the problem. The details were supplied to a software called DTPlanner, which models the problem as an MDP and solves for an optimal policy using
well known algorithms, such as value iteration and policy iteration. The policy that
maximizes the survival time while minimizing the risk of drug toxicity was adopted.
1.3 Current approaches
The main approaches that have been used in studying the problems discussed
above are given below.
1.3.1

Static models
In this approach, the decision problems are solved at several time instants and the

set of solutions are then presented as a dynamic strategy. Such a model presents a crude
approximation and leads to a sub-optimal solution.
1.3.2 MDP & SMDP
A Markov Decision Process (MDP) model consists of a set of possible states S, a
set of possible actions A, a reward function R(s, a). The actions can be of two types,
namely, deterministic and stochastic. Deterministic actions are those, where, for each
6

state and action, a particular new state is defined. Where as, for a stochastic action, for
each state and action, a probability distribution has to be specified over the next states.
The solution expected to a problem, by modeling as a Markov decision process is
an optimal policy. Optimal policy tells, which action to be followed in a particular state,
so that, the total expected reward could be maximized. Semi-Markov Decision Process
(SMDP) goes a step further in taking the time spent in a particular state also, into account
for analysis. Medical problems can fit into these mathematical models, though with some
assumptions and constraints.
1.3.3

Graphical formalisms
Many decision-making frameworks make use of graphical formalisms to easily

accommodate the complexities of the problems. These formalisms by themselves cannot
give a solution to a problem. They have an underlying mathematical framework, which
models the actual problem. These formalisms, as given below, are useful for easy
understanding of the problem. Below given are some of the formalisms in use.
1.3.3.1 Dynamic influence diagrams
Dynaimic influence diagrams are direct acyclic graphs. T.Y. Leong [32] depicted
a influence duagram, which is as shown in Figure 1. The squares denote the decision
nodes, the circles denote the chance nodes and the rhombus’ denote the value nodes.
Inside, each node, there is a number, which indicates the decision stage in which the
decision/event/value is considered. Arcs leading to chance and value nodes in the figure
denote the probabilistic dependencies and arcs leading to the decision nodes indicate the
informational dependencies. The possible value of the outcome of a chance node or a
7
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Figure 1. Dynamic influence diagram
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value node is embedded in each of them. One diagram is enough to model a situation
with any number of actions.
1.3.3.2 Markov cycle trees
In a Markov cycle tree, the branches of the tree come out of the root node, which
is called as the Markov node. For a given action, the leaf nodes represent the states at the
beginning and at the end of a decision stage.
The arcs indicate the possible outcomes and also the conditional dependencies
among the nodes. A utility function is always defined for each of the states in the
diagram. The number of Markov cycle trees for a given problem will be equal to the
number of actions available. The uncertainty in the problem and the variation with time
would lead to extreme complexity of the Markov cycle trees. T.Y. Leong depicted the
Markov cycle tree in [32], as shown in Figure 2.
0.72
Well

0.26
0.02

Sick

0.94

Dead

0.06

Well
Sick
Dead
Well

Dead
Dead

1.00
Leaf node
Probabilistic
dependence

Markov node
Chance node
Figure 2. Markov cycle tree
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1.3.3.3 State transition diagrams
As shown in Figure 3, the nodes denote the states and the arcs denote the possible
transitions given an action. The transition probabilities are denoted above the arcs. A
utility function is defined for each state in the diagram.
0.50
0.25
well

0.25

sick
0.50

0.25

0.25
dead

1.00
Figure 3. State transition diagram
1.3.3.4 Influence views
An influence view is a diagram wherein the events taking place in a single
transition are modeled. For each action defined in the problem, an influence view can be
drawn. This is very similar to the transition diagram, except that, in this, the events are
modeled as nodes whereas in a transition diagram, the states are modeled as nodes. Also,
in an influence view, a conditional distribution table is associated with each node, which
is comparable to the transition probabilities associated with the arcs in a transition
diagram, only difference being that the transition probabilities are far more difficult to
obtain than the conditional probabilities. Paolo Magni et al. [8] depict an influence view
10

as shown in Figure 4. The information obtained from an influence view can always be
obtained from a properly drawn transition view, except for the difficulty of obtaining the
exact transition probabilities from the existing medical databases concerning the problem.
Artificial Intelligence researchers have been working on the dynamic decision
problems with other methodologies, like the ones mentioned below. Sometimes,
statistical techniques and AI methods are being combined and used for modeling.

Age

NatDeath

Numeric node

Event node
Death

Death
State node

Disease

DisDeath

Event node

State node

Event node

Intervention

Intervention

State node

State node
Figure 4. Influence view

1.3.3.5 Decision trees
Decision trees have always been popular in sequential decision-making. The other
advantages of a decision tree are that, it can easily be translated into convenient if-then
rules. Constraints also can be easily imposed. However, the decision tree needs to be
11

learned through heuristic procedures, as the problem of finding the best tree is an NPhard problem. The major disadvantage of decision trees is that they are not suitable for
time varying problems.
1.3.4

Neural networks
A neural network consists of a set of nodes called the input nodes, output nodes

and intermediate nodes. Input nodes receive the input signals. Output nodes give the
output signals and a large number of intermediate layers contain the intermediate nodes.
Such networks can be built using special hardware, but most of them are just software
programs that can operate on normal computers.
There are two stages involved in the neural network learning,
Encoding stage: Neural network is trained to perform a certain task,
Decoding stage: Neural network is used to classify examples, make predictions
or execute whatever learning task is involved.
Different forms of neural networks are perceptrons, back propagation networks, and
kohonen self-organizing map.
1.3.5

Belief networks
Belief networks help in modeling phenomenon, which have an uncertainty

element. They deal with reasoning under uncertainty. Bayesian belief networks are
directed acyclic graphs with a set of nodes interconnected with arcs. Each node represents
an uncertain quantity or a random variable. The arcs link the variables, which have direct
influence over each other. The influences are shown over the arc with the help of
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conditional probabilities. Belief networks have applications in medical diagnostic
systems, weapons scheduling, and computer processor fault diagnosis, to name a few.
1.3.6

Genetic algorithms
These are basically adaptive, heuristic search algorithms based on the

evolutionary ideas of Charles Darwin. Their intelligent exploitation of a random search
within a defined search space to solve a problem makes them outperform other traditional
methods. Being good at solving problems, involving, finding optimal parameters, they
are especially useful in optimization.
Genetic algorithms can be applied to problems where the search space is large and
complex, domain knowledge is scarce and where mathematical analysis is not available.
Machine and robot learning, economic models, ecological models and automated
programming are some of the areas, for which, genetic algorithms have been applied.
1.3.7

Rough set theory
Rough set theory mainly deals with classification of data tables. It is one of the

techniques available to search large databases for meaningful decision rules and to
acquire new knowledge. It has found applications in medical data analysis, image
processing and voice recognition.
1.4 Brief description of the problem
One such decisio problem is the Hereditary Spherocytosis problem considered in
this thesis. In this disease the patient suffers from being anemic because of the red blood
cell destruction. If the patient is not cured, then there is an increasing risk of gall stone
formation, in addition to the red-blood cell destruction. On the other hand, if the
13

physician intervenes, in an attempt to cure the patient, a septic condition called sepsis can
develop.
Five possible interventions are available for the physician to choose from,
depending upon the patient’s condition. But, the problem lies in taking these decisions at
appropriate patient conditions so as to maximize the quality adjusted life days of the
patient. The patient’s condition changes continuously adding a dynamic dimension to the
problem. The changing condition of the patient, the side effects arising from the medical
interventions, and the amount of patient discomfort are some of the issues that a
physician has to continuously monitor and keep in mind while choosing the intervention
strategy.
1.5 Existing solution methodology
The problem of selecting an intervention strategy for Hereditory Spherocytosis
has been modeled in the literature using a static modeling formalism by Marchetti et al.
(1998) [7]. Later, it has also been modeled by Paolo Magni et al. (2000) [8] as a Markov
decision process to accomodate the dynamic perspective. The Markov cycle has been
fixed at one year. Influence views were used to describe the effects of the four possible
action choices. State of gallstones and state of spleen characterized a patient’s health
condition or states of the MDP. Quality adjusted life years is considered as the utility
function. The decision problem is to find the best action in every state of the patient to
maximize the quality adjusted life expectancy of a patient. Obtaining transition
probabilities for the states for every action and then solving for the optimal policy using
the existing value iteration algorithm constitute the solution procedure of the Markov
14

decision process. The transition probabilities are usually deduced from the conditional
probabilities obtained from the medical databases.
1.6 Need for better methods
There are two existing dynamic programming algorithms to solve for the optimal
policy of a MDP, namey, value and policy iteration. The computational complexity of the
value-iteration algorithm per iteration is quadratic in the number of states and linear in
the number of actions. In other words, each iteration can be performed in O(|A| |S|2)
steps. On the other hand, policy iteration converges faster than value iteration, but takes
O(|A| |S|2 + |S|3) steps per iteration. Thus, the computational complexity increases
enormously with even a slightest increase in the action and state spaces.
Most of the medical problems, when modeled as a MDP or as a SMDP, because
of the very nature of the problems, could end up with a large state space and a number of
possible actions. For such problems, it becomes difficult to arrive at the optimal policy
because of the issue of the computational complexity. The transition probability matrices
become very large requiring lot of memory to store all the states. Also, much
computational time is required for the value iteration or the policy iteration algorithms to
converge, which is not feasible. Therefore, computationally efficient approaches are
needed to obtain the optimal policy.
In the models studied in the literature, the state space of the Hereditory
Spherocytosis problem has been reduced considerably comprising of only the state of
gallstones and the state of spleen. Age and sex have not been considered. Moreover, time
after splenectomy, sepsis formation, and other complexities have all been ignored in
15

establishing the state space. Thus, even though the problem has been studied as a MDP,
significant elements of the problem have been left out to achieve simplicity giving only a
few states to deal with. As a result, the previous researchers were able to immediately
implement the value iteration or the policy iteration techniques and arrive at optimal
policies. But in reality, if all the relevant issues of the medical problem were to be taken
into consideration, the state space would grow quickly, requiring very high computation
time.
1.7 Approach considered
1.7.1

Reinforcement learning (RL)
Instead of directly applying value-iteration or the policy-iteration algorithms, an

indirect way to arrive at the optimal or, near optimal policy is by estimating a value
function using the method of reinforcement learning on a simulation model of the
problem. This is a viable alternative for obtaining near optimal policies for large scale
MDPs with considerably less computational effort than what is required for DP
algorithms. RL has two distinct advantages over DP. First, it avoids the need for
computing the transition probability and the reward matrices. The reason being that it
uses discrete event simulation as its modeling tool, which requires only the probability
distributions of the process random variables (and not the one step transition
probabilities). Secondly, RL methods can handle problems with very large state spaces
since its computational burden is related only to the value function estimation, for which
it can effectively use various function approximation methods such as, regression, and
neural networks. Therefore, when the model of an environment can be simulated and
16

inputs such as rewards can be given, reinforcement-learning algorithm can be applied to
get the optimal policy.
The hereditary spherocytosis problem that is considered in this thesis, has 1911
states and five actions. Therefore, the transition probability matrix is of the size (1911 ×
1911). The idea is to simulate the model of the situation and embed it into the
reinforcement learning technique. Thus, an optimal policy, which dictates, according to
the patient’s condition, what surgery to be performed and when it should be performed,
can be obtained. Also, this process would give the physician an idea about the QALY
(quality adjusted life years), the patient would enjoy, given, the optimal policy that is
followed. Such a decision support system hopes to aid the physicians in the decisionmaking process.
1.8 Summary of remaining chapters
The rest of the thesis is organized as follows. Chapter 2 is the literature review,
which discusses the existing literature on the medical decision problems, and the
approaches, which the researchers took to model them. Chapter 3 discusses in detail
about the problem being addressed and reveals the research objectives. Chapter 4 goes at
length into the proposed methodology, assumptions involved and describes the proposed
algorithm. It also discusses the future agenda. References and Appendices have been
provided at the end.
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CHAPTER 2
LITERATURE REVIEW

This chapter summarizes the existing research on the topic, “Medical-decision
making for the class of intervention problems.” It describes the work of selected
researchers and the solution methodologies adopted by them. Thus, the chapter gives an
idea, of the gradual progress in modeling and solving the decision problems from the
domain of medicine.
Research on medical decision-making is about a decade and a half old and a
fertile area for research. In this section, the different kinds of decision problems and
techniques, which evolved to solve them, have been described. The problems related to
medical interventions and clinical prognoses were being studied from long. But,
formulating these problems as models, using statistical methods and artificial intelligence
techniques began in the late 80’s.
2.1 Decision trees
Early papers attempted to model the medical decision problems, in clinical
settings, using decision trees. The reader is referred to Hollenberg (1984) [9] and Lau et
al. (1983) [10] for further discussion on decision trees and recursive decision trees,
respectively. But soon, it was realized that, this method involved assumptions, which
were far from reality.

18

Sonnenberg and Robert Beck (1993) [11] explained, why decision trees and
recursive decision trees, are not suitable to model decision problems in medicine. The
following explanation is adopted from their paper. Decision problems involve an ongoing
risk over time, because of which, there are two important consequences. One is the
uncertainty of the times at which the events occur. Second, is the repetition of a given
event. The decision tree modeling does not tell, as to when the events occur in time. Also,
there is a problem of assigning utilities to the terminal nodes, because they do not
represent an end but represent the prognosis of the patient for such an outcome, as is the
node. The second consequence, that is the repetition of a given event, can be modeled by
recursive decision trees. The problem in such modeling is that, the branches of the tree
might increase exponentially with each repetition, making it impossible to track. Hence,
Sonnenberg and Beck describe the markov model approach in this paper, which they felt
was appropriate to model the decision problems. With the description of the use of
Markov models for prognosis in medical applications by Beck and Pauker (1983) [12],
Markov models have been applied and analyzed on many decision-making problems in
medicine.
2.2 Markov cycle trees
In 1984, Hollenberg [9] introduced the Markov cycle trees, which have been used
by some researchers in modeling. In 1993, Sonnenberg et al. [11], explained that Markov
models are especially useful for decision problems, which involve risk, that is continuous
over time. Methods were also described to evaluate markov models. It was concluded
that, the ability of the markov models, to represent repetitive events and the time
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dependence of both probabilities and utilities, allows for more accurate representation of
the clinical settings. Three important ways of modeling in the Markovian manner were
discussed. Namely, the matrix solution, the cohort simulation and the markov cycle trees.
Also, the use of markov cycle trees was demonstrated by implementing the methodology
to a case history of a 42-year old man, who had had a kidney transplant. While the patient
was receiving normal immuno-suppressive drugs, a decision problem arouse. The
continuation of drugs might give rise to a complication, but if the drugs were stopped, the
kidney might be rejected. Therefore, the doctor had to decide on a treatment strategy, that
maximizes the quality of life expectancy of the patient. The author by comparing,
concludes that, Markov cycle trees are a suitable representation than decision trees. They
also stated that, Markov cycle tree is a formalism that combines the modeling power of
the Markov process with the clarity and convenience of a decision tree representation.
The above-described medical problem was modeled by Kassier et al. (1988) [13] as a
decision tree, prior to Sonnenberg and Beck.
2.3 Stochastic trees
At around the same time, Hazen (1992) [14] introduced, how medical decision
problems based on age-dependant mortality rates and declining incidence rates may be
modeled using stochastic trees. In this paper, it was shown that stochastic trees possess
important advantages over the markov cycle trees for medical decision modeling. The
stochastic tree is a continuous time version of a Markov cycle tree, useful for
constructing and solving medical decision problems, in which risks of mortality and
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morbidity may extend over time. Hazen (1993) [15] introduced the notion of factoring a
large stochastic tree into simpler components, each of which may be easily displayed.
This paper extends the idea of his previous paper, where stochastic trees were introduced.
2.4 Markov models
In the five part series of “Primer on medical decision making”, authors, Krahn
MD, Naglie G, Naimark D, Redelmeier DA, Detsky AS, (1997) [16,17,18,19,20] laid
considerable emphasis on the Markovian way of modeling. Interested readers can refer to
this excellent review, on decision problems and factors to be considered, while modeling
them. Issues like, choosing an appropriate problem, determining the trade-off between
accuracy and simplicity and deciding on a time frame have been discussed in Part 1 [16]
of the series. Part 2 [17] of the series discusses, the construction of a decision theoretic
approach for the giant cell arteritis (GCA) case. Part 3 [18] discusses the role of decision
trees in modeling. Part 4 [19] describes how to derive probabilities and also describes
bug proofing of decision trees. Part 5 [20] describes the same case as in Part 1, which has
been modeled using Markov analysis. Though the authors suggest the Markovian way,
they also leave a word of caution, that, model builders be aware of the pitfalls in this
approach and suggest that the analyst must weigh the simplicity and clarity of a
conventional tree against the fidelity of a Markov analysis. Part 5 concludes with the
inference, that, there doesn’t seem to be any significant qualitative difference between the
markov approach and the simple tree approach.
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2.5 Dynamic decision models
As different researchers tried to model the problems in different promising ways,
Leong (1991) [21] attempted to model the medical decision problems, by focusing on the
ontological features of the problem, like classes of actions, classes of events, classes of
outcomes, probabilistic dependencies and temporal precedence. This attempt was made
keeping in view, automating the construction of decision models in medicine. The
proposed system, described in this paper consists of a planner, which constructs a
decision model by accessing the medical knowledge database, and solves the model. The
solution is given to the user. The user helps the planner in doing its job, by giving certain
inputs. The results of this paper show that, to support dynamic decision modeling, the
structure of the knowledge base, must reflect the nature of both the decision problem and
the domain knowledge. Qualitative probabilistic network was used in modeling.
Leong (1992) [22] tried to represent knowledge, which is based on the context of
the problem, as a network. She believed that, complexity in the medical problem’s
knowledge occurs due to the variations in the contexts of the underlying phenomenon. In
that way, a framework has been proposed, which attempts to model the uncertain
knowledge in network formalism. In this paper, she explains, how to represent uncertain
situations in a network form, various components of the network and its applications. She
worked with the different structural relations, uncertain or behavioral relations, context
dependant notions and different relevant phenomenon of the problem, to model it as a
decision problem, though the implementation was left to be done.
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Leong (1993) [23] identified that Semi-markov decision process (SMDP) can be
taken as the common theoretical basis for solving the decision problems. Until this point
of time, simple Markov decision process (MDP) has been in use. In this paper, it was
explained that the complexity involved in the decision modeling could be avoided by
dealing directly with its underlying mathematical framework like an SMDP, which would
be more near to the practical situation. In an SMDP, the duration for which a patient is in
a particular state, which is yet another dimension of uncertainty, can also be taken into
consideration. It was also pointed out that, though, there are different formalisms suitable
for different kinds of problems, it should be realized that the underlying mathematical
framework for solving any of these problems is the same. It is either an MDP or an
SMDP. In this paper, the example of a typical medical decision problem, “The
management of chronic ischemic heart disease” was considered and modeled using three
different formalisms, namely, dynamic influence diagrams, stochastic trees and Markov
cycle trees. The pros and cons of the formalisms, were discussed and the paper concludes
with the notion, that, difficulty in modeling medical problems is not with the formalism,
but, is with the computational complexity of the value-iteration or the policy-iteration
technique of the underlying dynamic programming formulation, which cannot be
avoided. This paper can be considered as an important milestone in the research related to
this area.
In an attempt to provide a general framework for modeling and solving decision
problems, Leong (1994) [24], came up with a framework called, “Dynamic decision
modeling language” (DynaMol). The idea behind this, as she explains, is to have a
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general framework, which can handle any type of graphical formalism, as long as the
underlying methodology is an SMDP. According to the paper, the framework provides a
unifying task definition and a common vocabulary for the relevant decision problems and
also balances the trade-off between model transparency and solution efficiency in the
current frameworks. In this paper, Leong essentially describes the DynaMol design, the
dynamic decision grammar, which, comprises of terms related to modeling, the graphical
representation convention and the solution methods. The paper also summarizes the
assumptions involved in the design of DynaMol such as,
Same states should be valid through out the decision horizon,
Same set of actions is applicable in each state,
Transition probabilities can vary with time,
Semi-Markov decision process has limited memory regarding the past events. But
in some cases, the memory about previous states and actions could be important.
Leong notes that DynaMol should be extended to take care of such things.
Cao et al. (1996) [25] discusses, issues like the requirement for a multiple
perspective dynamic decision modeling language, the design of DynaMol framework, the
semantics and the grammar. Further literature on the same topic, can be obtained, in the
technical report by Leong (1994) [26]. This contains all the work done by her, in the area
of medical decision making until the year 1994.
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Leong (1996) [27] explained DynaMol in detail and implemented it on the
“Atrial fibrillation” case. The problem was modeled using influence views and SMDP as
the underlying framework. DynaMol models the problem, translates into the grammar of
the underlying framework, solves and finally analyses it.
Leong (1996) [28] illustrates, further improvements in the DynaMol design,
which accommodates “translators”. Graphical representations often help the analyst in
understanding and in easily accommodating all the complex factors of the medical
problems. But there are various types of graphical formalisms, like the influence views,
transition views, and markov cycle trees. Depending on the analyst, the problem can be
represented using any of the above and can be fed to DynaMol. DynaMol, then, translates
that particular graphical formalism, first to a transition view and then to the underlying
mathematical framework. This translation convention has been elaborately discussed in
this paper and the present DynaMol design was implemented and tested on the case study
of the atrial fibrillation case.
In 1998, Cungen Cao et al. [29] proposed a technique, through which diagnostic
test strategies can be obtained. This technique is very different from the MDP modeling
and uses the artificial intelligence techniques. It is similar to the decision tree technique
and gives a diagnostic test strategy from medical data. The authors call this modeling, a
‘strategy tree’. This tree can be induced from three types of information measures,
namely, K-level information gain, K-level gain ratio and K-level cost effectiveness. The
test, which provides the most information, has a larger information gain ratio and thus,
selected. The induction of the strategy tree depends on the previous tests selected. The
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cost of the test strategy is taken into consideration, to resolve in case of two tests of same
information gain ratio. Cost, here, is the reward obtained. In the authors’ words, the
building of the strategy tree is more or less similar to a decision tree building, except for
the difference, that the tree is also built in a level-by-level manner, in addition to the
divide-and-conquer manner.
Sunderesh et al. (1999) [33] extended the DynaMol framework, by embedding
abstraction mechanisms, which allows the end user to switch between representations of
the medical problem. This is called abstract modeling, which gives guidance to the user,
through the involved constraints in the problem.
Harmanec et al. (1999) [34] attempted to model the problem of “Severe head
injury management”, using a simple influence diagram. The decision problem involved
was to prescribe an optimal treatment plan to a severe head injury patient in an ICU
setting. This problem is different from other decision problems, considering its criticality
and large number of complex factors and parameters varying in minutes. Two ways of
parameter elicitation were proposed and the authors concluded that, more efficient
strategies for obtaining the numerical parameters involved are needed, even though the
problem produced reasonable recommendations.
An excellent critical review paper, came into the research area of medical
decision problems, when, Peter Lucas et al. (1999) [35] described, the various decisionmaking methodologies, used in the field of statistics and probability and in artificial
intelligence (AI). In this paper, restricted probability models, decision trees and Markov
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processes have been grouped under the statistical methods. Neural networks and
Bayesian belief nets were grouped under the AI techniques.
Qi and Leong (2001) [36] set up a method, for automatically constructing
influence views for the medical problems, directly from data. The conditional
probabilities for the influence views can also be automatically generated, using Bayesian
approach described by Cao et al. (1997) [37]. This methodology was accommodated in
DynaMol.
In the two papers, Lin et al. (2002) [38] [39] solved two problems, namely,
“Spontaneous pneumothorax” problem and the “chronic cough” problem, using the
SMDP modeling, which she proposed earlier and represented the problems in the
influence view formalism. Also, in 2002, YP Xiang and KL Poh [40] published a paper,
which models medical problems, which are time critical in nature. Usually, for decision
analysis, it takes considerable time. But in critical medical problems, the decision has to
be taken in a matter of minutes and that adds, the constraint of limited time, to the
decision problem. To formulate such problems, Xiang and Poh, proposed, a time critical
dynamic influence diagram (TDID), which can represent both space and time abstractions
within the model. Further, they proposed four algorithms to solve the TDID’s. The
authors follow a meta-reasoning approach to select the appropriate algorithm, from the
four algorithms, in terms of computational complexity and decision quality. This
methodology was implemented on a cardiac arrest problem and the results looked
promising.
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2.6 Obtaining the numbers
In the 1990’s, while various methodologies were being proposed for modeling the
medical decision problems, research for obtaining the required numerals (probabilities)
used in the models as inputs, was also progressing. The extraction of transition
probabilities and the action rewards, required in modeling, became an important topic of
research. The transition probabilities needed for the MDP, has to be, either obtained from
the domain experts or have to be extracted from the medical databases.
Cao and Leong (1996) [25] attempted to automate the learning of transition
probabilities and action rewards, required in the modeling of an MDP, from the medical
databases. It was suggested in the paper, that static comparison is an efficient method to
extract the transition probabilities, in which the transition cases have been divided into
three semantic classes. Using this method, the paper claims, that the issues of incomplete
and infrequent databases can be overcome to a considerable degree.
Cao et al. (1997) [37] proposed a Bayesian method, for automated learning of
conditional probabilities, from large medical databases. Obtaining probabilities from
domain experts, also, has been analyzed. Several issues on pre-processing raw data, for
applying to the decision problems were discussed. The learning from databases of
probabilities is based on the DynaMol framework. The proposed methodology was
implemented to the problem of colorectal cancer and results have been obtained.
In 1998, Cungen Cao et al. [41] published his Bayesian approach, to automatic
generation of conditional probabilities and its results. Lau and Leong (1999) [42],
proposed a framework, which can obtain the probability distributions for the decision
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problems from domain experts. These distributions are very important, as they represent,
the uncertainties in the system. This framework involves the doctors in getting
probabilities and also tries to minimize the bias in the probabilities given by them.
Zhao (2000) [43] proposed, an automated data pre-processing framework, which
uses database scripts, for processing databases before eliciting probabilities for dynamic
decision models. Thus, the eliciting of the numbers is by itself, an interesting area of
research in the domain of medical decision-making.
2.7 Static modeling
DT-Planner is a software package written in Ansi-C language. This is developed
by Paolo Magni et al. (1997) [6] to design and solve dynamic decision problems. It
makes use of influence views, to represent the problem. A user-friendly graphical user
interface, allows the user to navigate through the built in menus, to draw the influence
view of the problem and to input the conditional dependencies, involved, between the
events of the problem. The software models the problems as an MDP and then calculates
the transition probability matrix. DT-Planner solves the problem, using the value-iteration
algorithm to find the optimal policy. Elimination algorithm, by Rina Dechter (1996) [44],
is used to remove event variables from the influence view and to compute the equivalent
MDP. The problem of “allogenic bone marrow transplantation” has been implemented,
using this software and the optimal policy obtained was convincing.
The problem of the “Heriditary Spherocytocis” (HS) disease has been lurking
through the minds of researchers for quite some time. Patients with mild HS, have an
increased risk of gall stone formation and complications. Various treatments are
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available, out of which, Marchetti et al. (1998) [45] considered, three treatment strategies,
namely, ‘splenectomy’, ‘cholycystectomy’ and ‘no surgery’, so that the problem can be
simplified. A decision analysis was performed to see the effect of the three strategies, on
the quality-adjusted life expectancy.
The problem was modeled in the form of two phases. The first phase was
modeled as a decision tree, beginning with a decision. The outcomes of that decision,
depicted, surgery related mortality and accommodated, compliance to and adverse effects
of prophylaxis against infection. The second phase was modeled as a Markov cohort
analysis. But this didn’t serve the purpose of modeling the problem anywhere close to the
reality, as the model represented a static situation in the first phase and hence, the
dynamic element of the problem has been discarded.
Static modeling, requires the decision model to solve the problem at any age, as if
it were the only possible decision time, without considering the other decision time points
and hence, that the decisions might be reconsidered later. Also, the model proposed by
Marchetti et al. (1998) [45], allows, only one chance to take a decision and that too,
immediately.
Paolo Magni (2000) [8] modeled the above problem, by removing the two phases
and as an MDP, using influence views. The influence views and conditional probabilities
were fed to the DT-Planner (described above), to be solved by value-iteration technique
and arrive at an optimal policy, which maximizes the quality-adjusted life expectancy of
the patients. The results obtained, showed little improvement, when compared to the
static model and hence, an issue of investigation.
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Paolo Magni considerably simplified the HS problem, by making many
assumptions, many of which were far from reality. Also, the MDP model doesn’t seem,
either appropriate or accurate. Also, the calculation and consideration of the utility
values, which are in quality adjusted life years (QALY) is not very clear and convincing.
As such, medical problems are complex and the case of HS, is one of them. It seems to us
that proper modeling of this problem, as an MDP would result in a large state space, to
the order of 9.12 * 105. But, the model by Paolo et al. has a total of 11 states. As the state
space became dwarfed, the age-old dynamic programming algorithm (value-iteration
technique) could be applied and solved for an optimal policy using the DT-Planner.
However, for a large state space problem (as mentioned earlier in the introduction),
value-iteration technique would take forever to solve and would barely help.
Moreover, until now, in the literature, researchers have been modeling any kind of
decision problem as an MDP and solving it with only the available value iteration
technique.
This situation challenges us and motivates to propose a methodology, which can
model and solve any kind of medical decision problem, especially the ones with large
state spaces. We choose the ever-interesting HS problem for our research, summarized in
the following chapters.
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CHAPTER 3
RESEARCH OBJECTIVES

In this chapter, the problem of Hereditary Spherocytosis and its symptoms are
described, and the research objectives are stated.
3.1 Problem statement
The problem under consideration is the Hereditary Spherocytosis (HS), which is
the most common erythrocyte membrane disorder. Patients with this disease, suffer from
a chronic destruction of red blood cells. It is known, that in 60% of the cases, the disease
is severe and the patients become extremely anemic. In the rest 30% of the cases, the
patients are mildly anemic, with a hemoglobin level over 11 g/dl, a reticulocyte count of
3-6% and a bilrubin level of 1-2 mg/dl. These patients have an increased risk of gallstone
formation, because of the sustained erythropoesis, which predisposes them to episodes of
parvovirus induced aplasia and haemolytic crisis.
In the severely anemic patients, performing surgery, called splenectomy and
removing the site of red blood cell destruction is mandatory. But, in the case of mildly
anemic patients, there is no necessity to perform splenectomy immediately. These
patients have other treatment options available other than splenectomy. Thus, arises a
decision problem for the physician. Keeping in view, the side effects of splenectomy and
the availability of other treatments, the physician gets into a dilemma as to which would
be the best decision. He/she has to trade-off between, preventing adverse disease
consequences, and the risks posed by surgery, including, mortality, morbidity and post
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splenectomy infections. The other available treatments would comprise of no surgery,
where the patient is not treated but kept under observation to intervene at a later point of
time and the laproscopic cholycystectomy, which can prevent gallstone formation.
Therefore, the decision problem consists of coming up with the optimal
therapeutic plan, which dictates, depending on the patient’s condition, what surgery
should be performed, when it should be performed and in what condition can it be
performed, to maximize the quality of life of the patient under consideration.
3.2 Research objectives
The objectives of this research are the following,
to propose a methodology, which accommodates the modeling of the sequential
decision problems in medicine, as a MDP, and, to use a computer simulation
based reinforcement learning algorithm for an efficient solution,
to model the HS disease problem as a MDP and to obtain the results by solving it
using the proposed algorithm,
to compare the results obtained by the proposed methodology algorithm, with the
results obtained using dynamic programming algorithm.
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CHAPTER 4
PROBLEM FORMULATION AND SOLUTION METHODOLOGY

The Hereditary Spherocytosis problem has been formulated as a MDP. This
chapter describes in detail, the issues of modeling the problem as a MDP and its solution
methodology using a reinforcement learning algorithm. The simulation mechanism
involved and the ‘average reward reinforcement learning’ algorithm are also presented.
4.1 Problem formulation
Let the system state of a patient be described by the vector ‘s’. The system state
consists of the basic variables necessary to describe the patient’s state. These can be
called as the state variables and in every decision epoch, the physician chooses an
optimal action based on the current state of the patient. The important elements of the
patients’ state are the following variables.
Presence of gallstones
Presence of spleen
Presence of sepsis
Time elapsed after splenectomy is done (in years)
Presence of complication
Age and sex of the patient
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Therefore, the system state vector can be written as
s , t, c, a, ŝ ),
s = (g, s, ~

(4.1)

where,
g, describes the state of gallstones,
s, describes the presence or absence of spleen,
~
s , describes the presence or absence of sepsis,

t, describes the elapsed time after the surgery splenectomy is performed,
c, describes the presence or absence of a complication,
a, describes the current age of the patient at that particular decision epoch,

ŝ , describes the sex of the patient.
The underlying Markov chain of the MDP can be denoted by
S = {S n : n ∈ N , S n ∈ ξ },

(4.2)

where,
S n , denotes the system state at the nth decision epoch,
n, of the decision epoch index,

ξ , denotes the state space,
N ∈ {1,2,3,....,100}.
(See Appendix A for a detailed description of a MDP).
At any decision epoch n, S n ∈ ξ and the action is chosen as an ∈ A(s),
where, A(s) denotes the set of all possible actions in a state ‘s’.
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4.1.1

Elements of the MDP
The five important elements of an MDP are defined below for the problem under

consideration.
4.1.1.1 State space
The values associated with the state variables are as follows,
g = {1, 2, 3, 4, 5, 6},
s = {0, 1},
~
s = {0, 1},

t = {0,1, 2, ….95},
c = {0, 1, 2},
a = {1, 2, ….100},
~
s = {0, 1}.

Therefore, the cardinality of the system state space ξ is
| ξ | = 6 * 2 * 2 * 95 * 3 * 100 * 2 ≈ 13.68 × 105.
Total number of states in the associated transition probability matrix = 187.1424 * 1010.
4.1.1.2 Action space
The action vector is given as A = (a1, a2, a3, a4, a5) where, ai, i ∈ {1, 2, …5}
denotes the five intervention strategies. Every year, the physician can choose among the
following strategies.
a1, no prophylactic surgery
a2, prophylactic splenectomy
a3, prophylactic cholycystectomy
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a4, prophylactic splenectomy and prophylactic cholycystectomy
a5, open surgery (in the case of a complication occurring due to gallstones)
Not all of these five action choices, though, are available for every state. Therefore, the
availability of these actions depends on the state in which the patient is present.
4.1.1.3 Time horizon
In the present model considered, the maximum life span of a patient is assumed
to be 100 years. However, from every state s ∈ ξ , there is a nonzero probability of
natural death for the patient, apart from the probability of treatment related death
associated to certain states. Therefore, a patient is assumed to live for 100 years or less.
4.1.1.4 Decision epoch
The time between two decision epochs is considered to be 1 year. It is assumed
that a patient visits the doctor every year and the patient state is observed every year.
Therefore, the normal life span of a patient in years would equal the number of finite
decision epochs the Markov chain evolves through before reaching the state of death.
However, the quality adjusted life years that the patient enjoys is calculated using the
utility function and is different from the normal life span.
4.1.1.5 Transition probabilities
For every action ai ∈ A, there is a transition probability matrix P (ai) of the
Markov chain S, where P ss′ (ai ) represents the probability of moving from state s to

S′

under action ai. These transition probabilities can be obtained from domain experts or
abstracted from medical databases. Transition probabilities are assumed to be stationary.
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 s n +1 = s ′ 
P ss ′ ( a i ) = P 
.
 s n = s, a n = a i 

(4.3)

4.1.1.6 Rewards
To obtain the best strategy, there has to be some measure of an action’s value, so
that one can compare different actions. Hence, an immediate value is specified for
performing each action in each state.
Given the system state s at decision epoch n and action ai, if the next state is s ′ ,
the expected value of the reward is

γ n +1


R ss′ (ai ) = 
.
 s n = s, a n = ai , s n +1 = s ′ 

(4.4)

The rewards can be in any unit of interest. For example, monitory cost, lifespan or costeffectiveness ratios etc. The rewards are considered here as the Quality Adjusted life
Years (QALY) of the patient.
4.1.2

Quality adjusted life years (QALY)
The following sections describe quality of life adjustment, define a QALY and

explain various methods to derive quality weights for health states. Then, the proposed
method to obtain quality weights for health states is discussed. Finally, the procedure of
obtaining immediate rewards in terms of QALYs has been explained.
4.1.2.1 Utility function
The utility function used to compare the different strategies is based on the
Quality Adjusted Life Years (QALY) concept. Quality of life adjustment, measures the
degree to which surgical interventions, medical therapies and disease states diminish the
well being of patients. It is expressed as a number between 0 and 1, for every health state.
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The physician’s decision, coupled with the inherent changes occurring in the health of a
patient, can lead the patient to a decrease or increase in his/her quality adjusted life years.
A patient’s QALYs are observed every year, until the patient dies and the overall gain or
loss in QALYs is calculated. Thus, the objective function considered, is to maximize the
gain of the QALYs over the patient’s whole life. Hence, the utility function considered in
this thesis is based on the QALY concept. The assumption involved associating the value
function, concerning the utility is that, it is time separable. This implies, that it would be
possible, to calculate the overall value or the utility function as a combination of
functions, specified at each decision epoch.
4.1.2.2 QALY
According to Joshua graff Zivin (2002) [52], economists prefer to measure any
physical quantity in terms of their monitory value. But, health economists didn’t prefer
such a method because of the general belief that life is too precious to be priced, or that,
such a pricing is morally unacceptable. Therefore, health economists relied on other
methods, which measure the benefits from any health related activity that affects health,
in units of health outcomes. These units could be blood pressure units, cases of a
particular disease or life years. That’s how, quality-adjusted life years emerged as a
measure for health related outcomes.
Anytime when one talks about the outcome of a treatment or anything which
effects the health of a person, there are always two issues involved. One is the ‘quantity’
of life of the person affected because of the intervention and the other is the ‘quality’ of
life of the person, which measures not the number of years a person lives, but measures
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the years, which he/she lived comfortably with perfect health. The problem with using
only quantity of life as a measure is that it only considers whether people are alive or not
and is often expressed as life expectancy. On the other hand, quality of life takes care of a
number of issues concerning people related to their physical and mental capacity coupled
with the emotional aspects. Formally, a measure of quality of life is a quality adjusted life
year. In mathematical terms, it can be expressed as,
QALY = Life Expectancy x Quality of the remaining life years.
The quality of the remaining life years is quantified by placing a weight on time in
different health states. The concept of QALY provides a common basis to compare the
different kinds of interventions in terms of health related quality of life.
The idea of QALY is explained in brief below with the help of an example.
Suppose, a physician is trying to decide between two treatment strategies. Treatment A
has more probability of treating the disease than treatment B, but A leads to side effects
whereas B, has no significant side effects. Then, to compare the benefits of the two
treatments, the physician needs to know more than just the probability of success of each
treatment or life years saved. He/she should also know the amount of value which people
place on the health state with side effects related to the treatments, the quality weight for
the health state with side effects. This quality weight is also sometimes referred to as the
utility value of that particular health state. Suppose, the quality weight for the state with
side effects was estimated to be 0.75 (i.e.,) one year with side effects is equivalent to 9
months in perfect health. And if treatment A yields a total of 10 extra life years, then it is

40

said that treatment A yields 0.75 × 10 = 7.5 QALYs. This figure would then be
compared to the QALYs generated from treatment B to determine which yields greater
benefits.
4.1.2.3 Methods for deriving quality weights for health states
Research on the subject provides different methods to generate the quality of life
values or the quality weights, by observing the health states of the patients. These are also
often referred to as preference weights or utility values of the states. The methods to
obtain these weights fall into two broad categories. First category comprises of ,
rating scale technique,
standard gamble technique,
time trade off method.
Second category comprises of the multi-attribute health states survey.
The methods in the first category directly assess the quality weights with the help
of preferences of the individuals for well-described health states. Here, individuals are
asked to rank the given health state, relative to death and perfect health. The way of
ranking the health states differs from one method to the other. The second category
methods break down all the health states into a set of primary quality attributes, which
characterize those health states. Individuals are then asked to fill questionnaires designed
specially for the purpose. These multi-attribute survey answers are transformed into
quality weights using the first category techniques.
Below given is a brief description of the methods in the first category as explained
by Joshua graff Zivin.
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4.1.2.4 Rating scale
In this method, individuals are provided with a set of health states and are asked
to select the best and worst of those states. Then, those two states form the minimum and
maximum rating on a scale, usually the best being 1, and the worst state taking the value
zero. All the other states are placed on the scale according to the rating of the individual.
After this the respective ratings of the states are converted into quality weights of the
respective health states.
If, death is the worst state,
QualityWeight =
ForAnyGivenHealthState

ScaleValueOfTheHealthState
.
ScaleValueOfTheBestPossibleState

(4.5)

If, death is not the worst state,
QualityWeight =
ForAnyGivenHealthState

x− y
z−y

,

(4.6)

where, x = Scale value of the health state,
z = Scale value of the best state,
y = Scale value of death.
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1

Good Health State

Death

0

Worst Health State

Figure 5. Rating scale for quality weights
4.1.2.5 Standard gamble
In this method, the subject is asked to choose between two alternatives. The first
alternative has two possible outcomes.
Perfect health state of quality weight 1, for a length of time ‘t’
Immediately going to worst state of quality weight 0
The second alternative is living in the same imperfect health state for a time ‘t’ with
certainty. The probability of perfect health is denoted by ‘p’ and the probability of going
immediately to worst state is denoted by ‘ 1 − p ’. ‘k’ denotes the probability of being in

imperfect state. The quality weight for state ‘imperfect health’ is determined by varying
the probability ‘p’ until the subject is indifferent between the two alternatives. The weight
for state ‘k’ is equal to the value ‘p’.
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p

Perfect health
Quality weight =1
Alternative 1

1-p

Worse state
Quality weight =0
Imperfect health

Alternative 2

k

Figure 6. Standard gamble for deriving quality weights
This technique has got the uncertainty element in it. The quality weights are determined
by the risk of going to a worse state, that an individual is willing to accept to get an
improvement in his/her health.
4.1.2.6 Time tradeoff

This also, has two alternatives for the subject to choose from. Alternative 1 is life
in imperfect health state ‘k’ for time ‘t’ and then death. Alternative 2 is perfect health for
time ‘y’ and then death. But, t >y. time ‘y’ is varied until the subject is indifferent
between the two alternatives.
QualityWeightForState'k ' =

y
.
t

(4.7)

The aim of this method is to determine the amount of life expectancy an individual is
willing to sacrifice to increase the quality of their health.
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4.1.2.7 Multi-attribute health status surveys

In this method, the health states are characterized by important health attributes.
For example, the EuroQol system contains five attributes, namely, mobility, self-care,
anxiety/depression, pain or discomfort and usual activities. These attributes further have
levels, from which the subject chooses, according to the health situation. Under mobility,
for example, the subject can choose from,
no problems walking,
some problem waking,
confined to bed.
Then, these levels, which the subject chooses according to the health condition, are
transformed into quality weights in two steps. First step involves, determining a method
for aggregating the attributes and specification of a multi-attribute utility function.
Second, a large number of people are given questionnaires, which are designed to
incorporate all the attributes and the people are supposed to check the attributes with
which the health state can be defined. The same population is also asked to weigh the
health state using the standard gamble or the time tradeoff methods. Then, the two sets of
quality weights of health states are used to estimate the parameters of the multi-attribute
utility function. In the end, the result is a set of quality weights for all the possible
attributes and levels in the questionnaire, allowing any pattern of answers to be assigned
into a single quality weight that is bounded between 0 and 1.
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4.1.2.8 Cost-utility ratios

When the QALY values are combined with the costs of the interventions, costutility ratios can be obtained which can be used as another measure for differentiating
between interventions.
Mathematically,
CostUtiltyRatio =

CostOfInterventionA − CostOfInterventionB
.
No.OfQALYsByInterventionA − No.OfQALYsByInterventionB

(4.8)

These ratios indicate the additional costs required to generate a year of perfect health
(i.e.,) one QALY, through an intervention.
Though, all these methods are available to determine quality weights to the health
states, they all involve, a population of subjects. In the present thesis, because of lack of
access to actual individuals suffering from HS and also due to lack of resources for
conducting statistical surveys over a population of subjects, the above mentioned
methods cannot be followed to obtain quality weights. However, a method has been
developed for the purpose, which produces quality weights that are most consistent with
the health states involved in the model. This method is more on the lines of the multiattribute survey technique. This has been developed to obtain the quality weights, so that,
the proposed methodology can be checked for validity. Nevertheless, the methodology is
capable of incorporating quality weights obtained by any method available.
Research in area of ‘evidence based medicine’ is exploring ways to come up with
consistent mathematical methods to measure quality of life. For example, Bernard M. S.
van Praag and Ada Ferrer-I-Carbonell (2001) [53], discuss how QALY losses can be
assigned to various impediments and illenesses. A mathematical methos has been
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proposed to calculate the QALYs based on the age of the person and the results of the
paper shoe that the method is operationsl to evaluate the health situations of populations
and population subgroups. Nevertheless, the use of QALYs in decision-making does
mean that the different kinds of interventions are being distinguished from each other and
the differences between them made explicit.
4.1.2.9 Limitations of QALYs

QALYs are a mere indication of the benefits of a particular intervention. These
values could be far from being perfect as a measure of outcome. The following are some
of the limitations of QALYs,
lack of sensitivity when comparing two similar drugs, which are competitive,
preventive measures where the impact on health outcomes may not occur for many
years may be difficult to quantify using QALYs,
QALYs are highly dependant on age and life responsibilities. For example, it is
difficult to compare an athlete’s ankle fracture with that of a young boy, who have been
restored to some degree of mobility,
definition of perfect health is highly subjective.
Nevertheless, this procedure can aid anyone, wanting to use the system, at least in
prioritizing their expenditure, while choosing from a variety of interventions. New
techniques and therapies are bringing in much complexity for the health care
professionals as to which strategy to choose. Therefore, the concept of QALY and cost
utility ratios provide additional information, thus aiding the health care professionals in
decision-making.
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4.1.2.10 Uses of QALYs

The concept of QALY is used more as a comparison tool.
It can be used to identify public health trends for therapies to be developed
To assess the effectiveness of health care interventions
To determine state of health in communities
4.1.2.11 Method followed to derive quality weights for health states

As mentioned earlier, the method followed in the present thesis, to derive quality
weights to health states is similar to the multi-attribute method described. The health state
of the patients with HS can be characterized by the five attributes, namely, gallstones (g),
spleen (s), sepsis ( ~
s ), time (t) and complic (c). Further, these attributes have their
respective levels. Because of lack of resources and time, a statistical survey has not taken
place with the help of questionnaires. Nor, was there any sort of input from general
population regarding quality weights using standard gamble or the time tradeoff methods.
Hence, the parameters of the multi-attribute utility function are not estimated by
comparing the answers from the general populace, but are assigned some arbitrary values.
These values, though arbitrary, are consistent in deriving a set of quality weights for each
possible level chosen, according to the state of the patient, thus allowing any pattern of
answers to be aggregated into a single quality weight that is bounded between 0 and 1.
The consistency involved in obtaining the weights for all the health states involved in this
model, makes it promising to use in the present modeling methodology and to check its
validity.
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This method is further described in detail. The different attributes and their
respective levels, along with the arbitrary values, which they yield, have been shown in
Table 1. Depending on the health state, values are attained for all the five attributes,
according to their respective levels. These values are then summed up to arrive at the
quality weight of that particular health state. In this manner, the quality weights for all the
states (2685) have been derived.
Example 1
The quality weight for the health state s (3,1,0,0,1) would be (from Table 1)
0.15 + 0.0 + 0.10 + 0.05 + 0.0 = 0.30.
Example 2
The quality weight for the health state s (2,0,1,5,0) would be
0.20 + 0.30 + 0.00 + 0.0026 + 0.30 = 0.803.
Table 1. Quality weights
Note: All values are in generic units
Attribute

Level Description

Level

Value

Gallstones

No Gallstones

1

0.22

Asymptotic Gallstones

2

0.20

Occasional colics

3

0.10

Recurrent Colics

4

0.07

Gallbladder removed

5

0.15

No Gallstones (Death)

6

0
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Table 1. (Continued)
Attribute

Level Description

Level

Value

Spleen

Present

1

0

Absent

0

0.22

Present

1

0

Absent

0

0.23

Splenectomy not done

0

0

Splenectomy done

1 year

2 * 0.15625

Splenectomy done

2 years

3 * 0.15625

Splenectomy done

: years

: * 0.15625

Splenectomy done

: years

: * 0.15625

Splenectomy done

95 years

96 * 0.15625

1 year

15

Splenectomy done

2 years

15 – (1 * 0.15625)

Splenectomy done

3 years

15 – (2 * 0.15625)

Splenectomy done

: years

15 – ( : * 0.15625)

Splenectomy done

: years

15 – ( : * 0.15625)

Splenectomy done

: years

15 – (94 * 0.15625)

Present (due to
gallstones)
Present (due to spleen)

1

0

2

0

Absent

0

0.18

Sepsis

Time
Time (if
sepsis = 0)

Time (if
spleen = 1)

Complic

Splenectomy done
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4.12.12 Immediate rewards in terms of QALYs

The immediate rewards obtained are in terms of QALYs, when a state transition
occurs. Suppose, if a patient is in state 1, with quality weight 0.3 and an intervention
takes place. Due to the effect of the intervention, coupled with the body’s natural
metabolic rate, if he is found to be in state 2, with quality weight 0.8, then it is believed,
that the patient led the one year period within a health state of quality weight of 0.8 – 0.3
= 0.5. If the patient were to continue in state 1 for the one year period, without transiting
to state 2, because of the intervention, then the QALYs he would have enjoyed, would be
0.3 × 1 year = 0.3 QALYs. Another perspective can be the one of the patient to be in
state 2, right from the beginning, for the one-year period. Then, his QALY would have
been 0.8 × 1 year = 0.8 QALYs. But, in the case of the patient’s transition from state 1 to
state 2, he gained some quality weight owing to the transition, which occurred due to the
intervention. Thus, he gained 0.5 QALYs by transiting from a state, which provides 0.3
QALY’s to a state, which provides 0.8 QALYs. This gain in the QALYs is considered as
the immediate reward, due to the respective intervention.
These immediate rewards are aggregated to get the total expected reward, at the
end of the Markov cycle, which here, is indicated by the death of the patient. Hence, the
objective function, here, is to maximize the gain in the QALYs of a patient. These, total
expected rewards obtained for each patient is compared and the patient whose total
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expected reward is the highest, is selected. The policy, followed by that patient, becomes
the optimal policy, which dictates what action to be taken in what states, such that the
gain in the QALYs is maximized.
4.1.3

Hereditory spherocytosis

In this section, more details of the Hereditory Spherocytosis along with some
assumptions are given. This information is needed for simulating the treatment process.
4.1.3.1 Spleen

Spleen is the red-blood cell destruction site (detailed in the problem description),
which can be removed with the help of surgery. The presence of spleen poses an
increased probability of gallstone formation. The absence of spleen causes a high risk of
infectious condition known as sepsis. The incidence of sepsis depends on the length of
time, since the spleen has been removed by the surgery splenectomy. Less risk has been
associated for sepsis formation, of less than or equal to 4 years of spleen removal. More
risk is associated for the formation of sepsis, after 4 years of spleen removal. Spleen can
be removed with the help of surgery. At each decision epoch, a patient without spleen
will remain in the same situation, that is without spleen and a patient with spleen also
shall remain in the same condition, unless an action is taken to intervene the condition. It
is assumed that a patient visiting the doctor for the first time, would not have undertaken
any kind of prior treatment, or would not have undergone any surgical procedure relating
to his/her disease.
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4.1.3.2 Gallstones

The gallstone history of a typical HS patient can be classified as follows. The
gallstones state variable has been assigned levels depending on the state of gallstones of
the patient. The corresponding levels are shown in parenthesis below.
Patients without gallstones (level 1)
Patients with asymptotic gallstones, i.e. gallstones found through ecography but
without clinical procedures (level 2)
Patients with gallstones and occasional biliary colics, i.e. less than three episodes in
the last year (level 3)
Patients with gallstones and recurrent biliary colics, i.e. more than three episodes in
the last year (level 4)
Patients without gallbladder, because it has been removed (level 5)
Patients who are dead (level 6)
Hence, the gallstone state variable takes the values from 1-6. After each decision epoch
of the Markov chain,
a patient can remain in the same state of gallstones,
can develop asymptotic gallstones,
can develop occasional biliary colics or recurrent biliary colics, if he/she
already has asymptotic gallstones, or
can develop recurrent colics if he/she has already occasional colics.

53

Gallstones cannot develop if the gallbladder has been removed. A transition diagram of
the gallstones is shown in Figure 7. Gallstones can be removed with the help of surgery.
It is assumed that the presence of spleen increases the risk of gallstone formation.

No Gallstones
Asymptotic Gallstones

No Gallstones
(Gall bladder
removed)
Recurrent colics

Occasional colics

No Gallstones (Death)

Figure 7. State transition diagram for gallstones
4.1.3.3 Sepsis

The patients at any point of time can be classified on the basis of sepsis as,
patients who developed sepsis (level 1) and,
patients without sepsis (level 0).
As mentioned previously, the condition of sepsis occurs only when spleen is absent in a
patient and the risk of sepsis formation is dependant on the time elapsed after the spleen
removal by splenectomy. It is assumed that surgery cannot be done if a patient develops
sepsis.
54

4.1.3.4 Time

The time that elapses after the surgery splenectomy is kept in track. As said
before, there is less risk of formation of sepsis within 4 years of doing splenectomy and
more risk after 4 years. Therefore, in the simulation of the proposed framework, this issue
has been taken into account to give an idea as to how much time (in years) has elapsed
since splenectomy was done and accordingly, the risk of sepsis in the form of
probabilities has been assigned to the transitions occurring from one patient state to
another.
The assumptions here are that splenectomy can be done only for patients who are
5 years of age and above. Assuming that a person’s life span is 100 years, the time state
variable can take values from 5-100. After splenectomy is done, from then on, at every
decision epoch, the time state variable is incremented by a value of 1 indicating the
number of years that elapsed after the removal of spleen through splenectomy. Thus, the
value of the time state variable depends on the value of the spleen state variable. If spleen
shows a value of ‘1’, that definitely is an indication that the time value is ‘0’.
4.1.3.5 Complications

This variable keeps track of any complication in a patient. This could be any type
of complication, meaning any type of situation requiring immediate intervention.
Complications can be of mainly two kinds.
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Complication occurring due to the presence of gallstones denoted by the
complic (c) variable taking the value 1
Complication ccuring due to the presence of spleen denoted by the complic (c)
variable taking the value 2.
The condition of ‘no complication’ is denoted by a value zero taken by the complic (c)
variable. Acute cholecystitis and biliary pancreatitis are examples of complications due to
gallstones for which, an opensurgery may be required. Aplastic crisis is an example of
complication occurring due to spleen, for which splenectomy is the remedy. The
outcomes of the surgeries could be, that the patient is out of complication, implying that
the value of the state variable ‘complic (c)’ is turned to ‘0’. Another outcome of the
surgery could be surgical death, in which case also the ‘c’ variable takes the value of ‘0’.
When, complication is present, the value assigned to ‘c’ is 1. If there is no complication
in the current patient state, then the risk of occurrence of a complication in a future
transition state is dependant on the level of the gallstone state variable. As the level of the
gallstone variable increases, the probability of occurrence of complication increases.
When the level of gallstone state variable is 5 or 6, the complication variable (c) takes the
value ‘0’ in the next state, since for gallstone at level 5, no complication can arise as the
gallbladder has been removed. For gallstone in level 6 no complication can arise, as it
indicates death. If the complication value in the current
patient state is ‘1’, then a surgery is mandatory and the complication would have been
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removed in the next transition state. Then, the transitioned state would definitely have a
‘c’ value of ‘0’, concerning that particular complication, concerning that particular
complication.
4.1.3.6 Age

The decisions that a physician make might alter according to the age of a patient.
Therefore, age is an important state variable. This state variable can take the values from
1 to100, assuming that patients can be in the range of one to hundred years old. After
each decision epoch of the Markov chain, the age state variable is incremented by 1.
Age is not taken into consideration, as a state variable in the proposed simulation
mechanism, due to the lack of knowledge of how the domain experts change their
decisions depending on the age. But, the idea is that, age should be incorporated into the
MDP modeling as a state variable, as it would differentiate the state of a patient
depending on the age unlike the model of Paolo Magni et al.(2000)[8]. This variable if
incorporated would contribute considerably to the state space of the system.
Though, age is not considered a state variable, it is taken into account in the
present model, while dictating the optimal policy to the doctor who takes help of the
decision support system. This is achieved by obtaining different optimal policies,
according to the age of the patient. Usually, one optimal policy is obtained for a problem,
but here, when age is taken into consideration, patients of different ages, become
different optimization problems. The reason being, the maximum number of decision
epochs, which can be traversed by different age patients are different. Though, the
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methodology remains the same, it has to be applied, separately, to the different age
patients to arrive at the respective optimal policies. Thus, age contributes to the decision
making.
4.1.3.7 Sex

While resolving the tradeoff between the decisions to be taken, sex could be an
important factor. Hence, it is appropriate to be added as a state variable denoting the
patient state. This variable can take the values of ‘0’ for male and ‘1’ for female patients.
However, the value of this variable remains the same through the decision process.
Sex also, has not been incorporated in the model due to lack of knowledge to
approximate the behavior of the system based on this variable. In this thesis, sex has been
taken into account in the model building process , but not while simulating the model.
4.2 Model solution

The solution to an MDP is called a policy and it simply specifies the best action to
take for each of the states.
4.2.1

Simulation mechanism

The program ‘Medical decision making’ written in Java 2.0 programing language
simulates a patient arrival and assigns a starting state to the patient. After an action is
chosen, the patient goes to a transitioned state, from among a possible set of transition
states. A reward or utility is generally assigned for that particular action, which is called
the immediate reward. At the transitioned state, the decision maker again chooses an
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action and the patient makes yet another state transition. This cycle continues until the
patient dies or reaches the age of 100 after which the model assumes that patient is no
more.
The states and the actions taken in those states, until the patient’s death are noted.
Also, the immediate rewards and the total expected reward are noted. Thereafter the
model generates a new patient with a starting state and the cycle repeats.
The above-mentioned procedure is followed for a particular age group of patients.
The optimal policy obtained, also pertains, only to this age patients. Thus, different
optimal policies have to be obtained for different age patients. The methodology to obtain
the optimal policy, though, remains the same.
4.2.1.1 Assignment of the starting state

Considering the present problem of HS, the starting states where a patient can
begin the simulation, which corresponds to the situation of the patient when a doctor for
the first time examines him/her, are found to be eleven. Equal probability is assigned for
the patient to start in any of these 11 states. It should be recollected that the total state
space is 2685 (including death states).
4.2.1.2 Input parameters

The action to be taken in a particular state is dictated by the reinforcement
learning algorithm. When that action is performed in the respective state, the transitioned
state to which the system moves is obtained by simulating that action in that state, in the
simulation mechanism. This cycle repeats until the patient dies and the rewards are
collected.
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The numbers fed to the simulation program, which are the associated probabilities
of going from one state to other, can be changed according to the user’s knowledge
pertaining to the information of his/her HS patients. These numbers could also be
obtained from a medical database using tools like data mining or Bayesian learning.
However, the methodology remains the same and the simulation-based reinforcement
learning mechanism can work for any numbers, obtained in any manner.
The reinforcement learning algorithm developed in this research, to obtain the
optimal policy, which maximizes the QALY’s of a specific age patient, is presented next.
4.2.2

Average reward reinforcement learning

Here, the detailed steps of the algorithm are presented. This algorithm is a
modified form of the algorithm given by Gosavi (1999) [46], adapted to the medical
decision making problem considered, keeping in view the objective of maximizing the
QALYs.
4.2.2.1 RL algorithm

1. Let the iteration count m = 0.
Initialize a new patient arrival and assign a state(s) to the patient.
Initialize action values Q(s,a) = 0 for all s ∈ ξ and a ∈ A(s), and the average
reward ρ m = 0 ,
Initialize input parameters ( α ,α t )( β , β t )( γ ,γ t ) ,
where, α

represents learning rate,

β

represents average reward rate,

γ

represents the exploration rate.
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2. While m < MaxSteps, do.
If the system state at iteration m is s ∈ ξ ,
a) With a probability of (1 − γ m ) , choose an action a ∈ A(s) in state s,
corresponding to the maximum Q(s, a).
Otherwise choose a random exploratory action from
{A(s)} with probability

γm
(| A( s ) | −1)

.

b) Simulate the chosen action a for the current state s.
Let the system state at the (m+1)th decision epoch be s ′ . Let
the immediate reward be R (s, a, s ′ ).
c) Update the Q(s, a) value using the following equation
Q( s, a) ← (1 − α m)Q( s, a) + α m [ R( s, a, s ′) − ρ m + Qexp ( s ′)] .

(4.9)

d) Update the average reward ρ m +1 value as follows,



ρ m +1 ← (1 − β m)( ρ m) + β m m × ρ m +

R( s, a, s ′) 
.
m + 1 

(4.10)

e) Update the learning parameters α m +1 , β m +1 and the exploration parameter

γ m +1 following the Darken-Chang-Moody (1992) [47] scheme.
For any parameter θ with θ0 as its initial value and θt as the decay control
parameter, updating is done as follows,

θ m +1 =
where,

u=

θ0

,

(4.11)

m
.
(θ t + m)

(4.12)

1+ u
2
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The elements α , β and γ are the starting values, and α t , β t , γ t are
large constants chosen suitably to control the learning and decay rates.
f) Set current state s to new state s ′ , and m ← m+1.
3. If MaxSteps is reached, then go to step 4.
Else, if s ′ is the death state, then initialize a new patient arrival having a
starting state and go to step 2a.
Else, go to step 2a.
4. Simulate the system with the final form of the Q-matrices to estimate the average
value of the total QALY.
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CHAPTER 5
NUMERICAL RESULTS

In this chapter, the numerical results obtained by applying the proposed solution
methodology to the hereditary spherocytosis problem are presented. The solution
methodology was tested with different values of the algorithm design parameters. The
results presented represent the best solution.
5.1 Reinforcement methodology results

The solution methodology requires six design parameters. The design parameters
are the initial values of the learning parameters ( α , α τ ) for the Q-Values, learning
parameters ( β , β τ ) for the average reward ρ , and the exploration parameters ( γ , γ τ ).
The parameters α τ , β τ only affect the rate of decay of the corresponding learning
parameters and are initialized to a large value of 1012. The exploration decay parameter,

γ τ effects the rate at which exploration occurs and is initialized to 1011. The average
reward obtained from the RL methodology for various values of the exploration
parameter ( γ ) and a fixed set of values for the learning parameters are listed in Table 2.
The fixed values of the learning parameters ( α , β ) were obtained by trial and error.
Figure 8 shows a plot of the number of decision epochs versus the average reward
obtained in each decision epoch during the learning phase of the RL methodology
for different exploration parameter values, keeping the learning and the average reward
learning parameters at a fixed value of 0.1.
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Table 2. Results from the RL methodology
S. γ
No

Avg. QALY/year
Learning Phase

Avg. Total QALY
Learnt Phase

1

0

0.4356092

41.56283

2

0.1

0.4170014

41.37534

3

0.2

0.4346187

41.54974

4

0.3

0.444321

41.49474

5

0.4

0.4026054

41.15621

6

0.5

0.4007282

41.61528

7

0.6

0.390321

41.53495

8

0.7

0.4524216

41.95321

9

0.8

0.4392717

41.82469

10

0.9

0.4106183

41.32438

QALY = Quality adjusted life years
Note: All values are in generic units
Fixed values of the learning parameters ( α , β ) = (0.1, 0.1)
Fixed values of the learning decay parameters ( α τ , β τ ) = E12
Fixed value of the exploration decay parameter ( γ τ ) = E11
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0.5
0.45
0.4
0.35
0.3
0.25
0.2
0.15
0.1
0.05
0

Gamma 0.0
Gamma 0.1
Gamma 0.2

30993

28609

26225

23841

21457

19073

16689

14305

11921

9537

7153

4769

2385

Gamma 0.3
Gamma 0.4

1

Avg. Rwd, QALYs

Learning Phase Avg. Rwd

Gamma 0.5
Gamma 0.6
Gamma 0.7
Gamma 0.8
Gamma 0.9

# Decision Epochs

Figure 8. Average reward values for different exploration parameter values
The third column in Table 2 is the average reward in QALYs obtained for a
patient in one year. This reward is obtained as a consequence of the decisions made
during the learning phase of the RL methodology. The last column in Table 2 shows the
average total QALYs per patient during his/her life time, which is the objective of the
proposed methodology. These values are also called as the learnt phase values, because
while obtaining these values, the RL methodology uses the best policy obtained in the
learning phase. The corresponding combination of the design parameters associated with
the highest learning phase average reward value would give the optimal solution. Thus,
the highest average reward obtained during the learning, phase is 41.95321,
corresponding to an α = 0.1 , β = 0.1 , γ = 0.7 , α τ & β τ = E12 , γ τ = E11 . Hence, it can
be concluded that, the quality life that patients suffering from HS enjoy, would be, on an
average, around 42 years, assuming that the patient lives for 100 years unless he/she
encounters a surgical death or death due to side effects of a performed surgery.
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5.2 Value iteration approach

According to Sutton and Barto [49], the term “Dynamic Programming” refers to a
collection of algorithms that can be used to compute optimal policies given a perfect
model of the environment as an MDP.
Value Iteration is one such algorithm, which takes the transition probability
matrices of different actions of the system and the reward matrix of the system as inputs,
to compute the values of each state in the state space. Based on these values, the
algorithm outputs a best policy. The best policy is a vector consisting of the best actions
to be taken in the respective states such that the reward over the long run is maximized.
[Please refer Appendix A for a description of the value iteration algorithm].
In the present problem, neither the transition probabilities nor the rewards are
explicitly available. These have to be computed from the available information of the
respective outcomes of the state variables, and their quality weights. Computation of
transition probabilities from the known outcomes of various situations of a particular
medical problem is part of the ongoing research on medical decision support. In the
present thesis, a method is followed to obtain the transition probabilities and rewards
from the known possible outcomes of the different levels of the state variables.
The method followed is explained below.
5.2.1

Method to obtain transition probability matrices (TPMs)

As mentioned earlier in section 4.1.1.5, there exists always a probability
Pss′ ( ai ) of moving from state s to s ′ under action ai. In the present problem, it should be

noted that the states are characterized by the five state variables namely, gallstones(g),
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s ), time(t) and complic (c). These variables further consists of levels.
spleen(s), Sepsis( ~

Therefore in the HS problem, there always exists a probability of moving from one state
variable level to another level of the same state variable under action ai, in one decision
epoch, which is 1 year. These probabilities can be obtained from domain experts or
abstracted from medical databases. In the present thesis, reasonable values are assumed
for these probabilities for the five variables and are shown below. These are called
variable transition probabilities from this point forward.
Table 3. State-variable transition probabilities in a decision epoch
Variable

Condition

Gallstone ‘g’

Spleen = 0

Variable
Current
level
1

Variable
Transition
Level
1

Variable
transition
Probability
1

2

2
3
4
3
4
4
5
1
2
3
4
2

0.4
0.4
0.2
0.6
0.4
1.0
1.0
0.2
0.4
0.3
0.1
0.2

Variable
Current
level

Variable
Transition
Level
3
4

Variable
transition
Probability
0.5
0.3

3

3
4

0.3
0.7

3

Spleen = 1

4
5
1

2
Variable

Condition
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Table 2. (Continued)
Variable

Condition

Complication Spleen
‘c’
=0

Spleen=1

Variable
Current
level
4
5
Gallstone=1 0

Variable
Transition
Level
4
5
0

Variable
transition
Probability
1.0
1.0
1.0

Gallstone=2 0

0
1

0.97
0.30

Gallstone=3 0

0
1

0.93
0.07

Gallstone=4 0
Gallstone=5 0
Gallstone=1 0

0
1
0
0

0.90
0.10
1.0
0.93

Gallstone=2 0

2
0

0.07
0.88

1
2

0.05
0.07

0
1

0.83
0.10

2

0.07

0
1
2
0
2
1
0
1

0.78
0.15
0.07
0.93
0.07
1.0
1.0
5(TimeValue1)*0.0534

Gallstone=3 0

Gallstone=4 0

Gallstone=5 0
Sepsis ‘ ~
s’
Spleen=1
Spleen=0

1
0
0
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Table 2. (Continued)
Variable

Condition Variable
Current
level

Variable
Transition
Level
0

Variable
transition
Probability
0

Spleen ‘s’

0

0

Time ‘t’

1
1
1.0
0
0
1.0
TimeValue TimeValue+1 1.0

Spleen=1
Spleen=0

Variable
100-[5(TimeValue1)*0.0534]
1.0

Note: All values are in generic units
These variable transition probabilities are the transition probabilities associated
individually with each of the state variables. But the transition probabilities required for
the value-iteration algorithm are the transition probabilities of moving from state ‘s’ to
state ‘ s ′ ’. Therefore, a method is followed to get the state transition probabilities by
grouping the variable transition probabilities. A patient state ‘s’ is considered, which can
be called the current patient state. All the possible states to which state ‘s’ can transition,
under a particular action (ai) are figured out, depending on the state variable levels of the
considered current patient state ‘s’. These possible states are called transition states. After
that, the state variable levels of the current patient state are compared with the respective
levels of the state variables of each transition state. The transition probability associated
to transition from a particular state variable level of state ‘s’ to a different level of the
same state variable of a transitioned state ‘ s ′ ’ is noted from Table 4, which has been
called as the variable transition probability. Similarly, the transition probabilities for the
other variables are also attained from Table 4. All these variable transition probabilities
are summed up. Then another possible transition state is considered and the sum of the
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variable transition probabilities for its variables is obtained. In this way, the sum of
variable transition probabilities is obtained for all the possible states figured out. All these
sums are again summed up, which can be called as the total sum. Out of the total sum, the
percentage of the individual sums is calculated, which are the required transition
probabilities from state s to all the possible transition states.
In this way for all the 2685 states, under different possible actions, the transition
probabilities have been obtained and a transition probability matrix for each of the five
actions has been developed. The rows of each transition probability matrix represent the
probabilities of going from a particular state to all the other possible states in one
transition or one decision epoch, for a particular action.
5.2.2

Method followed to obtain reward matrix

To develop the reward matrix also, a similar method is followed. A patient state
‘s’ is considered and all the possible transition states ate figured out. The immediate
rewards obtained for transitions to each of the possible states are calculated using the
quality weights method given in section 4.1.2.11 and section 4.1.2.12. Then the
immediate rewards are multiplied with the respective transition probabilities of the
transition states. An average is taken over the products of the transition probabilities and
immediate rewards, to obtain the reward in QALYs of taking that particular action in the
state ‘s’. In this way, the immediate rewards obtained for all the states over all actions are
put in a matrix form, which is the reward matrix. The rows of this matrix are the states
and the columns are the five actions.
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The value iteration algorithm uses these TPMs and the reward matrix to compute
the actions which give the maximum value in each of the states. Sutton and Barto define
value of a state or action, as a function which estimate how good it is for the agent (here,
patient) to be in a given state or how good it is to perform a given action in a given state.
Sutton and Barto furthur explain that “how good” refers to the future rewards the agent
(here, the physician) can expect to receive in the future, which depends on what actions
are to be taken. After computing the maximum value in each of the states, value iteration
algorithm forms a policy, which consists of the actions corresponding to the maximum
value in each of the states. But, this need not be the optimal policy. This could be one of
the policies from the policy space. Therefore, the algorithm tries to improve the policy by
calculating the values for each of the states again. In other words, it updates the values of
the states using the below given update equation, which is another form of the Bellman
optimality equation.
M


Vnew ( s ) = min  Rsai + ∑ p( s , j , a i ) × Vold ( j ) ,
ai ∈ A ( s )
j =0



(5.1)

where, s is the current system state (here, patient state),
j is the transitioned system state,
M is the total number of states in the state space ξ of the system,
ai is the action being considered,
Rsai is the immediate reward obtained for performing action ai in state s,

(whose value is obtained from the reward matrix).
A(s) is the set of all actions possible in state s,
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p( s , j , ai ) is the transition probability to go from state ‘s’ to state ‘j’ with

action ‘ ai ’.
Theoretically, this updating of the values and improvement of the policy
continues forever, requiring infinite number of iterations to converge to the exact optimal
values and to obtain the optimal policy. But, in reality, the updating of the values and
improving the policy is stopped after a finite number of iterations when the values change
by only a small amount. The policy obtained is the optimal policy.
The average system reward by following the optimal policy obtained from the
value iteration algorithm is 43.8790.
5.3 Policy differences

The difference between the value iteration technique and the proposed
methodology is 1.21985, which is 1.22QALY’s or 445.25days.The percentage difference
between the two techniques is 2.825%. Part of the policies obtained by the help of these
two techniques is given in Table 3 showing some of the differences between them. These
differences partly contribute to the difference in the average reward obtained using them.
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Table 4. Differences in policies of value iteration and reinforcement learning

(3, 0, 0, 3,0)

Value
Iteration
Policy
2

RL
Policy
0

572

(3,0,1,2,0)

2

0

760

(4,0,0,1,0)

0

2

762

(4,0,0,2,0)

0

2

764

(4,0,0,3,0)

0

2

766

(4,0,0,4,0)

0

2

768

(4,0,0,5,0)

0

2

770

(4,0,0,6,0)

0

2

1520

(2,1,0,0,0)

2

3

1523

(3,1,0,0,0)

0

3

1526

(4,1,0,0,0)

0

2

1531

(5,1,0,0,0)

0

1

State
Position

State

384

Note: All values are in generic units
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CHAPTER 6
CONCLUSIONS

6.1 Concluding remarks

Medical decision making problems are typically characterized by a large number
of different patient health conditions and many available treatment choices. Predicting the
effect of a single treatment choice on the patient’s health might not be difficult. But,
predicting the effect of a chosen sequence of treatments, over the evolving health
conditions of the patient with time, is perhaps impossible.
Medical decision problems often involve such sequential treatment strategies
taken over a period of time. The objective of such treatment strategies involves choosing
the best treatment from the available choice, in every health state of the patient such that,
a preferred benefit measure is optimized. There is no existing framework to help analyze
such sequential medical decision problems to obtain an efficient solution.
This thesis develops an efficient solution methodology for obtaining treatment
strategies in sequential medical decision problems. The methodology involves modeling
of the problems as a Markov decision process, and obtaining a solution using a
reinforcement learning approach. Modeling as a Markov decision process accounts for
the sequential nature of the problem, and the reinforcement learning based approach
helps in obtaining a computationally efficient solution.
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A medical intervention problem, Hereditary Spherocytosis (HS), with five
treatment choices has been identified as a test bed to apply the methodology. In
particular, after the physician has diagnosed a patient suffering from HS, the physician
depending on the health condition of the patient tries to decide on a strategy, out of the
possible strategies available in that particular health state. The benefit measure chosen,
here, is the QALYs of a patient and the objective of the physician is to maximize the
quality of life of the patient, over the patient’s life. The solution obtained in terms of
average total QALYs that can be obtained over a patient’s lifetime has been compared
with the optimal solution obtained from the value iteration algorithm of dynamic
programming.
Experimental results using test data show that the proposed methodology can be
effectively used to solve sequential medical decision problems with great reduction in
computational effort when compared to the value iteration algorithms. Moreover, the
optimal solution obtained by the proposed methodology was found to be quite close to
that obtained using the value iteration algorithm of dynamic programming, hence giving
a near optimal policy. The percentage difference, in the average total quality adjusted life
years obtained per patient over the patients life, using the Value iteration technique and
the reinforcement learning technique is found to be 2.825%. The difference being
reasonable, it can be concluded that reinforcement learning is a viable alternative for the
dynamic programming algorithms in obtaining a computationally effective solution.
Moreover, reinforcement learning being a simulation-based methodology can be very
useful in solving large-scale sequential decision problems in medicine.
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6.2 Extensions to this work

Some of the extensions to this work are as follows,
a reward scheme that accounts for cost of interventions and quantity of life along with

the quality of life of the patient would make the model more realistic,
development of a methodology to abstract the outcomes of the various events, which
can also be called as transition probabilities, from a medical database using data mining
tools,
assumption that a patient lives for 100 years unless he encounters a surgical death or a
death due to the side effects and complications due to certain treatment strategies can be
relaxed to incorporate the natural death of the patient, which would be more realistic,
accommodation of factors like age and patient while assigning quality weights,
the issue that a patient being able to visit the physician whenever a problem arises,
and the physician being able to take a treatment decision at any point of time, has not
been incorporated in the present methodology. Therefore modeling the problems as a
semi-Markov decision process to account for the changes occurring in the condition of a
patient during a decision epoch, would considerably improve the model,
patient states, usually, in a medical scenario cannot be defined perfectly as they are
not fully observable. Therefore, modeling as a partially observable Markov decision
process (POMDP) would get the model much nearer to the real life scenario.
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Appendix A: MARKOV DECISION PROCESS

A Markov decision process is a stochastic process characterized by 5 elements,
namely, decision epochs, states, actions, transition probabilities and rewards. Also, there
may be an agent (decision maker) that controls the path of the stochastic process. At
certain points of time in the path, this agent intervenes and takes decisions, which affect
the course of the future path. These points are called decision epochs and the decisions
are called actions. At each decision epoch, the system occupies a decision making state.
A vector that uniquely characterizes the system may describe this state. As a result of
taking an action in a state, the decision maker receives a reward (which may be positive
or negative) and the system goes to the next decision-making state with certain
probability called the one-step transition probability. In a Markov process, the future state
of the system depends only on the current state and the action chosen in the current state.
A decision rule is a function for selecting an action in each state while a policy is a
collection of such decision rules over the state space. A more formal definition of MDP is
given next.
Sequential decision making problems, that are completely characterized by
Markov chains as their only underlying stochastic processes, are commonly referred to in
the literature as MDPs. Let,
X = {X n : n ∈ N , X n ∈ ξ }

(A.1)
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Appendix A: (Continued)

denote the underlying Markov chain of an MDP, where, X n denotes the system state at
the nth decision making epoch, ξ denotes the state space, and N denotes the set of
integers. At any decision making epoch n, where, X n = i ∈ ξ, the action taken is An = a
∈ Ai. Ai denotes the set of possible actions in state i and U Ai = A. Associated with any
action a ∈ A is a transition probability matrix P(a) of the Markov chain X, where P i j(a)
represents the probability of moving from state i to j under action a. A reward function is
defined as r: ξ × A Æ R, where, R denotes the real line, and r (i,a) is the expected reward
for taking action a in state i. It is assumed that the rewards are bounded, rewards and the
transition probabilities are stationary, and the state space is finite. Also, for the sake of
simplicity, markov chains that are aperiodic and unichain are only considered.
The solution algorithms for MDPs, such as policy and value iteration, find the
optimal stationary deterministic policy π * (which is a mapping π * : ξ Æ A) that
maximizes the reward criterion. A stationary deterministic policy refers to a policy that is
independent of time. The Bellman optimality equation, which lies at the heart of dynamic
programming methods like policy and value iteration algorithms, is stated next after
defining two important terms gain and bias.
The gain for an MDP is defined as the average reward per period for a system in
steady state under a given policy. When the system starts at any arbitrary state i and there
after follows policy π , gain is given as

ρ π = lim

N →∞

1 π N
E i  ∑ r( X
 n =1
N

N

, A N )  = ϕ r ,
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(A.2)

Appendix A: (Continued)

where, ϕ denotes the limiting probability of the Markov chain X, and r is the reward
vector {r(i,a) : i ∈ξ, a ∈ A}. The bias is defined as the expected total difference between
the reward and average reward. Hence the bias in an MDP starting at state i and
subsequently following policy π is given as

[

∞
π
π 
h ( i ) = E i  ∑ r( X
n =1

N

]

, A N ) − ρ π  .


(A.3)

A.1 Bellman optimality equation for average reward MDP’s

Under considerations of average cost for an infinite time horizon for any finite
unichain MDP, there exists a scalar ρ * and a value function R* satisfying the following
system of equations for all i ∈ ξ,



*
r ( i , a ) − ρ * + ∑ p ( i , a , j ) R* ( j )  ,

R ( i ) = max
a∈ A i 
j∈ξ


(A.4)

such that the greedy policy π * formed by selecting actions that maximize the right hand
side of the above equation is average reward optimal, where r(i,a) is the expected
immediate reward in state i, when an action a is taken, and p (i, a, j) is the probability of
transition from state i to state j, under action a, in one state.
The average reward value iteration algorithm, which is one of many algorithms
available for solving MDPs is given next.
A.2 The average reward value iteration algorithm

The value iteration algorithm is a method to iteratively obtain the optimal value
function and the corresponding optimal policy using the bellman optimality equation. The
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average reward version of the value iteration algorithm for MDPs (Puterman, 1994) [48],
is presented next.
Let Rm (i) be the total expected value of evolving through m stages starting at
state i ∈ ξ, and ψ is the space of bounded real valued functions on ξ.
Select R0 ∈ ψ , specify δ > 0 and set m = 0 and a state k* ∈ ξ
For each i ∈ ξ, compute Rm+1 (i) by

R

m +1



( i ) = max r( i , a ) − R m ( K * ) + ∑ p( i , a , j ) R m ( j ) .
a∈ Ai
j∈ξ



(A.5)

If sp (Rm+1 – Rm) < δ , go to step 4. Otherwise increment m by 1 and return to
step 2. sp denotes span, which for a vector ν is defined as span(ν ) = max ν (i) –
min ν (i).
For each i ∈ ξ, choose the action

d δ (i) as



m
d δ ( i ) = arg max  r ( i , a ) + ∑ p ( i , a , j ) R ( j ) ,
j∈ξ
a∈ A i



(A.6)

and stop.
A value iteration sweep through the whole state space simultaneously updates the
values in every iteration. This creates a considerable computational challenge, especially,
for problems with large state space.
Even under favorable conditions, convergence of the average reward value
iteration algorithm is very slow since Vn diverges linearly in n, becomes numerically
unstable. A relative value iteration algorithm avoids this difficulty, but does not enhance
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the rate of convergence. An asynchronous version of the relative value iteration avoids
the sweep through the whole state space by updating the value of one state at a time. Such
algorithms still require the complete knowledge of the system’s probability structure and
thus are difficult to implement for large systems. The computation of these quantities for
problems with very large state spaces can become almost impossible. Hence, obtaining an
optimal solution using these methods is often quite difficult.
In recent years, an alternative approach, called Reinforcement Learning (RL) that
is based on simulation-based stochastic approximation has become a topic of intense
research interest. Convergent algorithms based on this method have been shown to obtain
near-optimal policies for Markov decision problems with a considerable reduction in
computational effort. Reinforcement Learning algorithms have two distinct advantages
over DP algorithms. The first advantage is that they can handle problems with complex
reward and stochastic structures since they use simulation as a modeling tool. Secondly,
RL can integrate within its various function approximation methods (regression, neural
networks etc.), which makes it possible to solve problems with large state spaces.
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Reinforcement Learning (RL) is a way of teaching learning agents (decision
makers) to predict the policy. This is accomplished by assigning rewards and
punishments for their actions based on temporal feedback obtained during active
interactions of learning agents with dynamic systems. Any learning model basically
contains 4 elements, which are the environment, learning agents, and a set of actions for
each agent and the environmental response (sensory input). Each learning agent selects
an action and their actions collectively will lead the system along a unique path till the
system encounters another decision making state. During this state transition, the agents
gather sensory outputs from the environment, and from it, derives information about the
new state and immediate reward. Using the information obtained during the state
transition in conjunction with the algorithm, the agent updates its knowledge base and
selects the next action. As this process repeats, the learning continues to improve its
performance. A reinforcement-learning model is depicted in Figure 9. The learning agent
provides the environment (system) with actions, and in return receives the sensory inputs
that determine the next state and the reward or punishment resulting from its most recent
action. On the nth step of interaction, based on the system state xn = i and the
reinforcement values R(i) = {R(i,a) : a ∈ Ai} for the a available actions, the agent takes
an action a, where R* (i) = maxaR(i,a). The system evolves stochastically in response to
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the input state-action pair (i,a) and results in outputs concerning the next system state xn+1
and the reward (or punishment) r (xn,xn+1) obtained during the transition. These system

Simulated system model

System
environment

Response
Xn+1

r(Xn, Xn+1)
i

I
Xn+1

Action a

R
r(Xn, Xn+1)

i

R

Learning
agent

Learning algorithm
Figure 9. A reinforcement learning model
outputs serve as the sensory inputs for the agent. From these sensory data, the input
function I helps the agent in perceiving the new system state.
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Using the information about the new state (from I) and the sensory data about the reward
(punishment), the reinforcement function R calculates the new action values R(i) for the
previous state (xn = i).
There are two different factors that determine the utility of an action. One is the
immediate reward and other is the action value of the state to which the transition occurs
as a result of that action. When a system visits a state, the decision maker chooses an
action with highest (or lowest for minimization) action value (greedy policy). Initially,
the action values for all state-action pairs are assigned arbitrary equal values (e.g.,
zeroes). When a system visits a state for the first time, a random action gets selected
because all the action values are equal. As the system revisits the state, the learning agent
selects the action based on the current action values, which are no longer equal. For
ergodic processes, the states continue to be revisited and consequently the agent gets
many opportunities to refine the action values and the corresponding decision making
process. Sometimes, the learning agent chooses an action other than that suggested by the
greedy policy. This is called exploration. As the good actions rewarded and bad actions
punished over time, for every state, the action values of a smaller subset (one or more) of
the actions tend to grow and others diminish. The learning phase ends when a clear trend
appears with one or more actions in every state being dominant. These actions constitute
the decision policy vector.
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There are three different types of reinforcement learning models that have been
studied most. In the finite horizon model, the agent optimizes the expected reward for a
finite (h) number of steps,
which is given by

E  ∑ r n  ,
 n =0 
h

(B.1)

where rn is the scalar reward received from the nth step of the horizon. Hence, the agent’s
action on the first step is the h-step optimal action, on the second step h-1 step optimal
action, and so on. The other two RL model types are infinite horizon models with average
reward and discounted reward as their performance measures, which are given as

1 h 
lim E  ∑ γ n  ,
h →∞
 h n=0 

(B.2)

and
∞
E ∑ γ n r n  ,
 n=0


(B.3)

where, γ (0 < γ < 1) is the discounting factor used per period. The concept of average
reward is discussed briefly next.
B.1 Average reward RL

In most systems, the optimal total expected reward is finite either because of
discounting or because of a reward-free termination state that the system eventually
enters. In most situations, however, discounting is inappropriate and there is no natural
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reward-free state. This makes it meaningful to optimize the average reward per stage
starting from a state i, which is defined for any policy π = ( π 0, π 1, π 2,…..) by

1  N −1

E  ∑ ( r ( i , a , j ) | i0 = i )  ,
R ( i ) = Nlim
→∞ N
 k =0

π

(B.4)

assuming that the limit exists, where r (i, a, j) is the reward received by taking action a in
state i and going to state j.
B.2 Model based RL

One of the biggest difficulties encountered in solving MDPs with complex
probability structures is to set up the transition probability matrices (TPM). If the TPM is
available through mathematical calculations, one can always use classical methods like
value iteration or policy iteration. Model-based RL usually computes the functions, such
as transition probabilities and rewards using simulation. As the simulation progresses, the
learning agent gets an improving estimate of these functions, and uses them in solution
algorithms (e.g., Sutton, 1992) [49]. But the curse of dimensionality remains a problem
with model-based RL. The ongoing research by the RL community is directed toward
solving the dimensionality problem.
B.3 Model free RL

The model-based RL algorithms estimate the transition probabilities using
simulation. Hence, a strong disadvantage of DP (i.e., the need for computation of
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transition probabilities) is not avoided. The algorithms that obviate this need are referred
to as model-free algorithms. Model-free algorithms can infer R-values directly from
sample paths generated by simulation. For problems with large state spaces, the R- values
need to be represented by some standard function approximator, such as a feed forward
neural network, or a nearest neighbor Kernel regression algorithm.
Model-free algorithms belong to a class of stochastic iterative algorithms, of
which a usual updating scheme for action values can be described as follows. Suppose
that when an action a is chosen in state i, it results in an immediate reward of rimm(i,a) and
a system transition to state j. Then, the action value for the state-action pair (i,a) is
updated as follows.

[

]

~
R new ( i , a ) = ( 1 − α ) Rold ( i , a ) + α r imm ( i , a ) + R( i , a ) ,

(B.5)

~
where, α is the learning rate, and R (i,a) is an estimate of R (i,a) calculated from the
~
feedback obtained during the system simulation. The exact form of R (i,a) depends on the
algorithm chosen and also on the performance metric. Q-learning and R-learning
(Kaelbling et al., 1996) [50], SMART (Das et al., 1999) [51], RELAXED-SMART
(Gosavi, 1999) [46] are all examples of model-free RL.
B.4 RL and DP

The relationship between DP and RL, which has its foundation in the DP
framework, is discussed here. RL uses an interactive style of learning to obtain the
optimal actions through trial and error.
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The algorithms that drive the learning agent use the so-called reinforcement
values that are actually related to the value function in DP are given below.
J ( i ) = maxa R( i , a )

∀i, a ∈ A(i ) ,

(B.6)

where, J (i) is the value function for state i, R(i,a) is the reinforcement value of taking
action a in state i, and A (i) is the set of actions available in state i. RL calculates the
reinforcement values (action values) for each state-action pair iteratively (using the well
known Bellman equation) whenever a state-action pair is visited by simulating the
system. DP, on the other hand, iterates over the reinforcement values of each state-action
pair using the Bellman equation and pre-calculated transition probability and reward
values. Hence, the primary difference between RL and DP is that RL stochastically
approximates the system evolution through its state-action pairs, and DP considers
random but stationary system state-action evolution.
B.5 RL and temporal difference methods

Here, the concept of temporal differences with reference to RL is discussed. The
concept of temporal differences (TD) is central to the development of all algorithms in
RL whether model-based or model-free. In this section, the following notational
convention is used. For any given trajectory i0, i1,….., iN, with iN = 0, and policy π = ( π 0,

π 1,….), let r (i, π i, j) be the reward obtained by going from state i to state j under action
π i. Also, let i k = 0, for k > N, and also r (i k, π k, i k+1) = 0 for k >= N. It is assumed
further that for any value function vector R π (.), R π (0) is zero.
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For a trajectory (i0, i1,.….., iN) that is generated, the reward estimates (value function)
R π (i k) , k=0,….,N-1, can be updated as follows,
π
π
R ( i k ) ← R ( i k ) + γ ( i k )( r( i k ,π k ,i k +1 ) +
( r( i k +1 ,π k +1 ,i k + 2 ) + ....... + ( r( i N −1 ,π N −1 ,i N ) − Rπ ( i k )).

(B.7)

Note that the above equation is actually the first step of policy evaluation in policy
iteration methods. The update formula can be rewritten, for R (i N) = 0, as follows,
R π ( i k ) ← Rπ ( i k ) + γ ( r( i k ,π k ,i k +1 ) + Rπ ( i k +1 ) − Rπ ( i k )) + ( r( i k +1 ,π k +1 ,i k + 2 ) + Rπ ( i k + 2 )
− Rπ ( i k +1 ))...... + ( r( i N −1 ,π N −1 ,i N ) + Rπ ( i N ) − Rπ ( i N −1 ))

(B.8)
The above equation is equivalent to Sutton’s TD (1) update and can be expressed as
R π ( i k ) ← Rπ ( i k ) + γ ( d k + d k +1 + ... + d N −1 ) ,

(B.9)

where, d k denotes the kth temporal difference and is given by
π
π
d k = r( i k ,π k ,i k +1 ) + R ( i k +1 ) − R ( i k ) .

(B.10)

The temporal difference d k represents the difference between an estimate of the
value function (r (i k, π k, i k+1) + R π (i k+1)) based on the simulated outcome of the
current stage, and the current estimate R π (i k). Thus the temporal difference provides an
indication as to whether the current estimates R(i) should be raised or lowered.
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